Sep 4, 2024 | 2024, Past Events, Press Releases
Dr. Samuele Cazzamalli, Head of Chemistry at Philochem, will be awarded the 2024 EFMC Prize for Young Medicinal Chemist or Chemical Biologist in Industry. 2024_EFMC_Prize_for Young_Medicinal_ChemistJul 16, 2024 | 2024, Past Events, Scientific
Dr. Samuele Cazzamalli is giving a presentation entitled “DNA-Encoded Chemical Libraries for the Discovery of Highly Potent Tumor-Targeting Ligands and for the Development of Anti-Cancer Small Molecule Therapeutics”. Follow the link for more...Jul 9, 2024 | 2024, Events, Investors, Past Events
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact us at IR@philogen.com or follow the link register to the event.May 24, 2024 | Past Events
Prof. Dr. Axel Hauschild, on behalf of Philogen, is giving a presentation about the Phase III PIVOTAL study on May 31st, entitled “Phase 3 study (PIVOTAL) of neoadjuvant intralesional Daromun versus immediate surgery in fully resectable melanoma with regional skin...May 24, 2024 | Past Events
Dr. Ettore Gilardoni (Head of Mass Spectrometry) will attend the 72nd ASMS conference in Anaheim (2-6 June 2024) and present a poster entitled: “Mass Spectrometry evaluation of glycosylation variants and SP2/0 Host Cell Proteins during downstream processes: the case...May 24, 2024 | Past Events
Dr. Andrea Galbiati is giving a presentation about Philochem’s FAP ligand platform on June 9th, entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”. Dr. Samuele Cazzamalli is presenting a poster about...
Recent Comments